We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




X-rays Show How Nanoscale Structure of Bones Resist Strain

By Biotechdaily staff writers
Posted on 23 Nov 2006
Scientists have just discovered the way deformation at the nanoscale takes place in a bone by studying it with the synchrotron x-rays. More...
This study clarifies the enormous stability and deformability of bones. The hierarchical structure of bones makes them able to sustain large strains without breaking, in spite of being made of fundamentally rigid units at the molecular level.

Bone is comprised of two different elements: half of it is a stretchable fibrous protein called collagen and the other half a brittle mineral phase called apatite. These components make this biomineralized tissue very strong and durable. At the same time, to understand how this construction is achieved and functions, scientists from the Max Planck Institute of Colloids and Interfaces (Potsdam, Germany) combined their efforts with the European Synchroton Radiation Facility (ESRF; Grenoble, France). Utilizing x-rays, they were able to see for the first time the simultaneous re-arrangement of organic and inorganic components at a micro- and nanoscale level under tensile stress. The study's findings were published November 4, 2006, in the online edition of the journal Proceedings of the [U.S.] National Academy of Sciences.

The scientists realized that when strain/pressure is applied to a bone, this is absorbed by soft layers at effectively lower length scales, and less than a fifth of the strain is actually noticed in the mineral phase. The soft structures form a single rigid unit at the next level, enabling the tissue to maintain large strains. This is why the brittle apatite remains shielded from excessive loads and does not break.

The researchers also showed that the mineral crystallites are nonetheless very strong, capable of carrying more than two to three times the fracture load of bulk apatite. Their small size preserves them from large cracks. This is the first experimental evidence for this effect in biomaterials--small particles resist failure more successfully.

The scientists conducted studies on ID2 beamline at the ESRF. They tracked the molecular and supramolecular rearrangements in bone while they applied stress using the techniques of x-ray scattering and diffraction in real time. The high brilliance of the x-ray source enabled the tracking of bone deformation in real time.

These findings provide new insights in the design principles that make healthy bone so fracture resistant. This study may also contribute to medical as well as technologic developments. "The outcome of this research may contribute to a future development of bio-inspired and new nanocomposite materials. On a medical level, it may help to understand how a molecular level change can make whole bones more prone to fracture in diseases like osteoporosis,” explained Dr. Himadri Gupta, first author of the article.




Related Links:
European Synchroton Radiation Facility
Max Planck Institute of Colloids and Interfaces

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.